An AI tool developed by Mayo Clinic researchers can identify brain activity patterns linked to nine types of dementia, according to a study published June 27 in Neurology.
The tool, called StateViewer, analyzes and compares fluorodeoxyglucose PET scan imaging to a database of scans from patients with confirmed dementia diagnoses. The tool then identifies patterns associated with nine specific dementia types, including Alzheimer’s disease.
Trained and tested on more than 3,600 scans, the tool helped researchers identify dementia type in 88% of cases. The tool also improved brain scan interpretation times and accuracy, according to a June 27 news release from Mayo Clinic.
David Jones, MD, director of the Mayo Clinic Neurology Artificial Intelligence program, led development of the tool.
Read the full study here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
